View live charts, options flow & technicals for Cencora, Inc. →
Open Dashboard
Cencora, Inc. (COR) is a healthcare company in the medical distribution industry with $332.77B in trailing revenue trading at a 23.4× trailing P/E — analyst consensus: buy.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Key Statistics
Market Cap
$59.59B
Revenue (TTM)
$332.77B
EPS (TTM)
$13.37
EPS (Fwd est.)
$19.81
Employees
47,000
Trailing P/E
23.36
Forward P/E
15.77
PEG Ratio
0.66
Price / Sales
0.18
Price / Book
19.53
EV / EBITDA
12.88
Beta (5Y)
0.57
Analyst Consensus
Consensus
Buy
Analyst Price Target
+18.3% upside
Target: $369.31
Annual Revenue & Net Income
RevenueNet Income
'22
$238.59B
$1.70B
'23
$262.17B
$1.75B
'24
$293.96B
$1.51B
'25
$321.33B
$1.55B
Earnings History
Quarter
Actual EPS
Estimate
Result
Aug 2026
$4.48
$4.34
Beat (+3.2%)
May 2026
$4.75
$4.73
Beat (+0.5%)
Feb 2026
$4.08
$4.04
Beat (+1.0%)
Nov 2025
$3.84
$3.79
Beat (+1.4%)
Next Earnings Report
Cencora, Inc. is next expected to report earnings on 04 Nov 2026.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order p…
What is COR's market cap?
Cencora, Inc. has a market capitalization of approximately $59.59B.
What is COR's P/E ratio?
Cencora, Inc. trades at a trailing P/E ratio of 23.4x and a forward P/E of 15.8x, which is below the broad market average of ~25x.
How much revenue does COR generate?
Cencora, Inc. generated $332.77B in trailing 12-month revenue.
What do analysts say about COR?
The analyst consensus rating for Cencora, Inc. is buy, with a mean price target of $369.31. That implies +18.3% upside from the current price.
When does COR report earnings?
Cencora, Inc. is next scheduled to report earnings on 04 Nov 2026.
Does COR pay a dividend?
Yes. Cencora, Inc. pays a dividend with a current yield of 0.76%, at an annual rate of $2.40 per share.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for Cencora, Inc. on Apsis Markets.